Health News Releases

  • Today February 7
Iodine prills – produced by SQM
October 14, 2022 09:35
GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media
GE Healthcare’s Pharmaceutical Diagnostics business has announced a long-term agreement with Chile-based mining company, Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchan
Mr. Tan Kong Hwee, Executive Vice President of the Singapore Economic Development Board (EDB) and Fl
October 13, 2022 16:30
Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific
Reaffirming its bold ambition to become the leading dermatology company in the world, Galderma today announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific re
Trueman Man Clinic Network Demonstrates Its Excellence in Gynecomastia Surgery in Korea with 25,700 Operations
October 13, 2022 13:30
Trueman Man Clinic Network Demonstrates Its Excellence in Gynecomastia Surgery in Korea with 25,700 Operations
Trueman Man Clinic Network announced that it has performed more than 25,700 gynecomastia operations as of September 2022 from 2010. Trueman Man Clinic Network is a renowned hospital for male-specific
October 12, 2022 17:20
Approval of delisting of Vifor Pharma AG's registered shares
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (SWX:VIFN) (Vifor) announced today that Vifor has received approval for the delisting of the totality of Vifor's regis
October 12, 2022 17:10
Sermo Surveys Reveals 87% of Global Physicians Feel There is a Lack of Clinical Guidelines on How to Treat Long Covid in Patients
A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that the majority of physicians feel there is a lack of clinical guidelines to diagnose and treat L
October 11, 2022 11:35
DENTALIS Animal Health Develops Products to Improve the Oral Health of Companion Animals
Animal health veterans and human dental experts have combined and formed a start-up company dedicated to the development of superior oral health care products for companion animals, currently developi
October 07, 2022 16:28
ProDERM Study Results of octagam® 10% Treatment in Patients With Dermatomyositis Published in the New England Journal of Medicine
Octapharma announced today the results from the ProDERM study on the efficacy and safety of octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been publish
October 06, 2022 21:00
Aleph Farms Expands Global Leadership Team with Key Appointment and New Office in the United States
Aleph Farms, the first cultivated meat company to grow steaks directly from non-genetically engineered animal cells, today announced the addition of Kevin Benmoussa as its Executive VP and Chief Finan
October 05, 2022 17:15
Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements
Boehringer Ingelheim announced today that Cowtribe is the first recipient of investment and non-financial support from the Boehringer Ingelheim Social Engagement (BI SE) initiative, a program which ai
October 05, 2022 14:30
Frazier Life Sciences Adds Experienced Biopharmaceutical Executive to Team
Frazier Life Sciences announced the addition of Jan Møller Mikkelsen as a Senior Advisor. He has over 30 years of experience as a biopharmaceutical executive. Mr. Mikkelsen founded Ascendis Pharma
October 04, 2022 16:42
DentalMonitoring Expands into Japan
New office in Tokyo; bringing smarter dentistry solutions to Japan. DentalMonitoring, the leading global provider of smart dentistry solutions, is setting foot in Japan to serve the Asian market wi
October 04, 2022 15:30
Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation
Treatment of cancer using one’s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, rad
October 04, 2022 11:40
The Estée Lauder Companies Launches 2022 Breast Cancer Campaign to Honor 30th Anniversary and Positively Impact the Global Breast Cancer Community
In the 30 years since Evelyn H. Lauder launched The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign) and co-created the Pink Ribbon in 1992, The Campaign’s mission to help create a breast
September 30, 2022 10:30
Burjeel Holdings Lights Up Burj Khalifa With New Campaign Featuring Shah Rukh Khan
A month ahead of his birthday, Indian actor Shah Rukh Khan lit up the world’s tallest building, The Burj Khalifa, on Wednesday evening, in a brand campaign for the UAE-based conglomerate Burjeel Holdi
September 30, 2022 09:10
Monrol Will Establish a Legal Entity and Manufacturing Facility in Germany
Following an ongoing assessment of its entire operation, Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has decided to establish a legal entity and manufacturing facility in Germany. The new facil
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
September 29, 2022 13:43
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New
September 28, 2022 17:10
Biocytogen to Present at BioJapan2022, Introducing Innovative R&D Platforms, Bispecific ADC Programs and Pipeline Progress
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will host a seminar at the BioJapan2022 Conference on Friday, October 14. The seminar, consisting of 3 modules, will introduc
THUNDERBEAT Open Fine Jaw Type X surgical energy device.
September 28, 2022 16:34
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM) Open Fine Jaw Type
September 27, 2022 17:40
New Survey from Philip Morris International Reveals Strong Societal Support for Disruptive Innovations to Drive Public Health Progress
A new international survey released today by Philip Morris International Inc. (PMI) (NYSE: PM) reveals that despite broad public support for disruptive innovation to address global challenges, issues
Michelle Bonfilio
September 27, 2022 17:15
Covetrus Names Michelle Bonfilio as Chief People Officer
Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and
September 23, 2022 13:30
Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660
Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) issued a positive vote for RBX2660,
September 22, 2022 15:00
Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
Merck, a leading science and technology company, today announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. (NMS) for the next-generation highly selective an
September 22, 2022 14:35
Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck
Nerviano Medical Sciences S.r.l. (NMS), a member of the NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, announced today the signing
September 20, 2022 17:20
Galderma Debuts The Sensitive Skincare Faculty, a Global Expert Group to Improve Understanding and Management of Sensitive Skin
Reinforcing its commitment to advancing dermatology for every skin story, Galderma announced today the formation of a global Sensitive Skincare Faculty, which will focus its efforts on helping people
September 20, 2022 10:30
Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States
Takeda (TSE:4502/NYSE:TAK) and Enel North America today announced the signing of a long-term virtual power purchase agreement (VPPA) for the electricity delivered to the power grid from a 79 megawatt
25 per page50 per page75 per page100 per page